CHA Vaccine Research Institute (KOSDAQ: 261780)

CHA Vaccine Research Institute Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	107,730	151,036	131,749	293,364	-	-
Market Cap Growth	-5.45%	14.64%	-55.09%	-	-	-
Enterprise Value	77,387	123,500	97,133	290,192	-	-
Last Close Price	4030.00	5650.00	4985.00	11100.00	-	-
PE Ratio	-	-85.97	-19.63	-14.05	-	-
PS Ratio	291.79	513.51	734.04	586.73	-	-
PB Ratio	3.43	4.26	3.95	7.41	-	-
P/FCF Ratio	-21.18	-27.11	-23.38	-54.13	-	-
P/OCF Ratio	-21.60	-28.53	-25.39	-61.90	-	-
EV/Sales Ratio	208.78	419.89	541.18	580.38	-	-
EV/EBITDA Ratio	-14.03	-20.98	-16.05	-49.70	-	-
EV/EBIT Ratio	-12.97	-19.24	-15.01	-47.69	-	-
EV/FCF Ratio	-13.03	-22.17	-17.23	-53.55	-	-
Debt / Equity Ratio	0.15	0.12	0.71	0.53	11.98	-0.59
Debt / FCF Ratio	-0.81	-0.78	-4.19	-3.85	-4.70	-1.63
Asset Turnover	0.01	0.01	0.00	0.01	0.00	-
Quick Ratio	53.01	48.57	2.18	2.50	5.20	0.59
Current Ratio	57.40	52.44	2.20	2.50	5.21	0.59
Return on Equity (ROE)	-13.93%	-5.09%	-18.40%	-89.44%	-	-
Return on Assets (ROA)	-8.89%	-7.56%	-6.40%	-8.35%	-14.99%	-
Return on Capital (ROIC)	-9.65%	-8.29%	-6.88%	-9.40%	-31.48%	-
Earnings Yield	-4.12%	-1.16%	-5.10%	-6.28%	-	-
FCF Yield	-5.51%	-3.69%	-4.28%	-1.85%	-	-
Buyback Yield / Dilution	-1.60%	-0.69%	-13.39%	-30.03%	-	-
Total Shareholder Return	-1.60%	-0.69%	-13.39%	-30.03%	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.